121 related articles for article (PubMed ID: 8837713)
1. No evidence for association of dopamine D2 receptor variant (Ser311/Cys311) with major psychosis.
Sasaki T; Macciardi FM; Badri F; Verga M; Meltzer HY; Lieberman J; Howard A; Bean G; Joffe RT; Hudson CJ; Kennedy JL
Am J Med Genet; 1996 Jul; 67(4):415-7. PubMed ID: 8837713
[TBL] [Abstract][Full Text] [Related]
2. Association study of bipolar disorder using a functional polymorphism (Ser311-->Cys) in the dopamine D2 receptor gene.
Craddock N; Roberts Q; Williams N; McGuffin P; Owen MJ
Psychiatr Genet; 1995; 5(2):63-5. PubMed ID: 7551964
[TBL] [Abstract][Full Text] [Related]
3. No association of dopamine D2 receptor molecular variant Cys311 and schizophrenia in Chinese patients.
Chen CH; Chien SH; Hwu HG
Am J Med Genet; 1996 Jul; 67(4):418-20. PubMed ID: 8837714
[TBL] [Abstract][Full Text] [Related]
4. Dopamine receptor D2 Ser/Cys 311 variant is associated with delusion and disorganization symptomatology in major psychoses.
Serretti A; Lattuada E; Lorenzi C; Lilli R; Smeraldi E
Mol Psychiatry; 2000 May; 5(3):270-4. PubMed ID: 10889529
[TBL] [Abstract][Full Text] [Related]
5. Association of dopamine D2 receptor molecular variant with schizophrenia.
Arinami T; Itokawa M; Enguchi H; Tagaya H; Yano S; Shimizu H; Hamaguchi H; Toru M
Lancet; 1994 Mar; 343(8899):703-4. PubMed ID: 7907680
[TBL] [Abstract][Full Text] [Related]
6. No major role for the dopamine D2 receptor Ser-->Cys311 mutation in schizophrenia.
Laurent C; Bodeau-Péan S; Campion D; d'Amato T; Jay M; Dollfus S; Thibault F; Petit M; Samolyk D; Martinez M
Psychiatr Genet; 1994; 4(4):229-30. PubMed ID: 7712120
[TBL] [Abstract][Full Text] [Related]
7. Association of structural polymorphism of the dopamine D2 receptor gene and alcoholism.
Higuchi S; Muramatsu T; Murayama M; Hayashida M
Biochem Biophys Res Commun; 1994 Nov; 204(3):1199-205. PubMed ID: 7980596
[TBL] [Abstract][Full Text] [Related]
8. Dopamine DRD2/Cys311 is not associated with chronic schizophrenia.
Crawford F; Hoyne J; Cai X; Osborne A; Poston D; Zaglul J; Dajani N; Walsh S; Bradley R; Solomon R; Mullan M
Am J Med Genet; 1996 Sep; 67(5):483-4. PubMed ID: 8886166
[TBL] [Abstract][Full Text] [Related]
9. Lack of association between dopamine D2 receptor gene Cys311 variant and schizophrenia.
Tanaka T; Igarashi S; Onodera O; Tanaka H; Fukushima N; Takahashi M; Kameda K; Tsuji S; Ihda S
Am J Med Genet; 1996 Apr; 67(2):208-11. PubMed ID: 8723049
[TBL] [Abstract][Full Text] [Related]
10. Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: Ser311Cys polymorphisms of the dopamine D2-receptor gene and schizophrenia.
Itokawa M; Arinami T; Toru M
J Pharmacol Sci; 2010; 114(1):1-5. PubMed ID: 20716857
[TBL] [Abstract][Full Text] [Related]
11. Insertion/deletion variant (-141C Ins/Del) in the 5' regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder. Short communication.
Stöber G; Jatzke S; Heils A; Jungkunz G; Knapp M; Mössner R; Riederer P; Lesch KP
J Neural Transm (Vienna); 1998; 105(1):101-9. PubMed ID: 9588764
[TBL] [Abstract][Full Text] [Related]
12. A structural polymorphism of human dopamine D2 receptor, D2(Ser311-->Cys).
Itokawa M; Arinami T; Futamura N; Hamaguchi H; Toru M
Biochem Biophys Res Commun; 1993 Nov; 196(3):1369-75. PubMed ID: 7902708
[TBL] [Abstract][Full Text] [Related]
13. Association between different psychotic disorders and the DRD4 polymorphism, but no differences in the main ligand binding region of the DRD4 receptor protein compared to controls.
Weiss J; Mägert HJ; Cieslak A; Forssmann WG
Eur J Med Res; 1996 Jun; 1(9):439-45. PubMed ID: 9353244
[TBL] [Abstract][Full Text] [Related]
14. DRD2 Ser311/Cys311 polymorphism in schizophrenia.
Shaikh S; Collier D; Arranz M; Ball D; Gill M; Kerwin R
Lancet; 1994 Apr; 343(8904):1045-6. PubMed ID: 7909081
[No Abstract] [Full Text] [Related]
15. No association of the Ser/Cys311 DRD2 molecular variant with schizophrenia using a classical case control study and the haplotype relative risk.
Verga M; Macciardi F; Pedrini S; Cohen S; Smeraldi E
Schizophr Res; 1997 May; 25(2):117-21. PubMed ID: 9187010
[TBL] [Abstract][Full Text] [Related]
16. DRD2 Ser311/Cys311 polymorphism in schizophrenia.
Nanko S; Hattori M; Dai XY; Fukuda R; Kazamatsuri H
Lancet; 1994 Apr; 343(8904):1044. PubMed ID: 7909078
[No Abstract] [Full Text] [Related]
17. DRD2 Ser311/Cys311 polymorphism in schizophrenia.
Asherson P; Williams N; Roberts E; McGuffin M; Owen M
Lancet; 1994 Apr; 343(8904):1045. PubMed ID: 7909080
[No Abstract] [Full Text] [Related]
18. Identification of two novel polymorphisms and a rare deletion variant in the human dopamine D4 receptor gene.
Cichon S; Nöthen MM; Catalano M; Di Bella D; Maier W; Lichtermann D; Minges J; Albus M; Borrmann M; Franzek E
Psychiatr Genet; 1995; 5(3):97-103. PubMed ID: 8746407
[TBL] [Abstract][Full Text] [Related]
19. Further evidence supporting the association between the dopamine receptor D2 Ser/Cys311 variant and disorganized symptomatology of schizophrenia.
Serretti A; Lilli R; Lorenzi C; Smeraldi E
Schizophr Res; 2000 Jun; 43(2-3):161-2. PubMed ID: 11001590
[No Abstract] [Full Text] [Related]
20. Genotype-phenotype studies in bipolar disorder showing association between the DAOA/G30 locus and persecutory delusions: a first step toward a molecular genetic classification of psychiatric phenotypes.
Schulze TG; Ohlraun S; Czerski PM; Schumacher J; Kassem L; Deschner M; Gross M; Tullius M; Heidmann V; Kovalenko S; Jamra RA; Becker T; Leszczynska-Rodziewicz A; Hauser J; Illig T; Klopp N; Wellek S; Cichon S; Henn FA; McMahon FJ; Maier W; Propping P; Nöthen MM; Rietschel M
Am J Psychiatry; 2005 Nov; 162(11):2101-8. PubMed ID: 16263850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
